Literature DB >> 16818370

TLR9 in health and disease.

Jörg Vollmer1.   

Abstract

Toll-like receptor 9 (TLR9) is specialized for the recognition of pathogenic nucleic acids. TLR9 is expressed in intracellular compartments where it responds specifically to pathogen DNA. Several factors contribute to the ability of TLR9 to discriminate between self and foreign DNA. Regulatory mechanisms of the innate and adaptive immune system exist that balance the immune responses mediated by TLR9. Short synthetic CpG oligodeoxynucleotides are used to induce controlled and directed TLR9-dependent stimulation and are effective immune modulators in preclinical and clinical studies. This review will summarize the interplay between TLR9-dependent opposing stimulatory and regulatory effects in innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818370     DOI: 10.1080/08830180600743107

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  26 in total

1.  Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Authors:  Maroof Hasan; Gabriela Lopez-Herrera; K Emelie M Blomberg; Jessica M Lindvall; Anna Berglöf; C I Edvard Smith; Leonardo Vargas
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

2.  Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses.

Authors:  Sibylle Tluk; Marion Jurk; Alexandra Forsbach; Risini Weeratna; Ulrike Samulowitz; Arthur M Krieg; Stefan Bauer; Jörg Vollmer
Journal:  Int Immunol       Date:  2009-03-30       Impact factor: 4.823

3.  Altered lymphocyte proliferation and innate immune function in scrapie 139A- and ME7-infected mice.

Authors:  In Soo Cho; Daryl S Spinner; Richard J Kascsak; H Cliff Meeker; Bo Sook Kim; Seung Yong Park; Georgia Schuller-Levis; Eunkyue Park
Journal:  Viral Immunol       Date:  2013-05-08       Impact factor: 2.257

Review 4.  Toll or toll-free adjuvant path toward the optimal vaccine development.

Authors:  Ken J Ishii; Shizuo Akira
Journal:  J Clin Immunol       Date:  2007-03-17       Impact factor: 8.317

5.  Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells.

Authors:  Roop Gill; Xiangcai Ruan; Christoph L Menzel; Seung Namkoong; Patricia Loughran; David J Hackam; Timothy R Billiar
Journal:  Shock       Date:  2011-02       Impact factor: 3.454

6.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

Review 7.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

8.  Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.

Authors:  Elina I Zuniga; Li-Ying Liou; Lauren Mack; Marilyn Mendoza; Michael B A Oldstone
Journal:  Cell Host Microbe       Date:  2008-10-16       Impact factor: 21.023

Review 9.  Modulation of NK cell activity by CpG oligodeoxynucleotides.

Authors:  Zuhair K Ballas
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  Toll-Like Receptor 9-Dependent AMPKα Activation Occurs via TAK1 and Contributes to RhoA/ROCK Signaling and Actin Polymerization in Vascular Smooth Muscle Cells.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Safia Ogbi; Theodora Szasz; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.